VeriMomdisodium lauroamphodiacetate hamilelikte güvenli mi?
No harmonised CLP classification, no SCCS/SCCP or other regulatory opinion identifying reproductive/developmental hazard for disodium lauroamphodiacetate; the Cosmetic Ingredient Review (CIR) assessment of fatty amphocarboxylates (which includes disodium lauroamphodiacetate) found no reproductive/developmental concerns when used as cosmetic surfactants. Regulatory registration dossiers list physico‑chemical/toxicity data but do not report harmonised reproductive hazard. ([cir-safety.org](https://www.cir-safety.org/sites/default/files/TR_FattyAmphocarboxylates_092025.pdf?utm_source=openai))
Pregnancy-safe products containing disodium lauroamphodiacetate
Related ingredients
Frequently asked questions
- disodium lauroamphodiacetate hamilelikte güvenli mi?
- No harmonised CLP classification, no SCCS/SCCP or other regulatory opinion identifying reproductive/developmental hazard for disodium lauroamphodiacetate; the Cosmetic Ingredient Review (CIR) assessment of fatty amphocarboxylates (which includes disodium lauroamphodiacetate) found no reproductive/developmental concerns when used as cosmetic surfactants. Regulatory registration dossiers list physico‑chemical/toxicity data but do not report harmonised reproductive hazard. ([cir-safety.org](https://www.cir-safety.org/sites/default/files/TR_FattyAmphocarboxylates_092025.pdf?utm_source=openai))
- disodium lauroamphodiacetate emzirirken güvenli mi?
- No data located showing milk transfer, lactation toxicity, or breastfeeding-specific adverse effects. CIR/regulatory reviews for amphocarboxylates do not identify breastfeeding hazards; exposure from rinse‑off cosmetic use is expected to be minimal. No peer‑reviewed studies show reproductive/developmental or lactation toxicity for this ingredient. ([cir-safety.org](https://www.cir-safety.org/sites/default/files/TR_FattyAmphocarboxylates_092025.pdf?utm_source=openai))
- disodium lauroamphodiacetate bebek cildi için güvenli mi?
- No evidence of increased hazard to infants in reproductive or developmental endpoints. Mechanistic data for reproductive toxicity are absent. However, because this is a surfactant with some dermal bioavailability under standard testing and infant skin has higher absorption/SA:weight, I increase exposure score by +1 for baby skin (0–3 yr) for topical/rinse‑off use; CIR/regulatory reviews do not identify infant‑specific toxicity. ([cir-safety.org](https://www.cir-safety.org/sites/default/files/TR_FattyAmphocarboxylates_092025.pdf?utm_source=openai))
- VeriMom disodium lauroamphodiacetate nasıl puanlıyor?
- VeriMom disodium lauroamphodiacetate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte disodium lauroamphodiacetate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.